Cervi-M cervical cancer methylation gene detection officially on the road press conference invited Shuanghe Hospital Vice President Lai Hongzheng to speak, the research lasted ten years, the domestic methylation results have finally been applied to the clinic, confirmed that the smear combined with methylation gene detection has 93% sensitivity, clinically confirmed that it can assist in smear screening is insufficient, has been adopted by three domestic medical centers, and will be fully sold in hospitals and clinics in the future, and will become a new generation of cervical cancer screening weapon. The Cervi-M testing process was demonstrated on the spot, and the media responded enthusiastically, and was broadcast in real time on the same day by ZOSE News.
